Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C.

ABSTRACT:

Background

Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C).

Objectives

Study the outcomes of institutional thromboprophylaxis protocol for primary venous thromboembolism (VTE) prevention in children hospitalized with acute COVID-19/MIS-C.

Methods

This single-center retrospective cohort study included consecutive children (aged less than 21 years) with COVID-19/MIS-C who received tailored intensity thromboprophylaxis, primarily with low-molecular-weight heparin, from April 2020 through October 2021. Thromboprophylaxis was given to those with moderate to severe disease based on the World Health Organization scale and exp

SUBMITTER: Schmitz AH 

PROVIDER: S-EPMC9357887 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature